#379 - The atopic triad is associated with increased Atopic Dermatitis-related healthcare utilization and expenditures in pediatric patients: results from the Medical Expenditure Panel from 1996-2015
Nishadh Sutaria, BS, Youkyung S. Roh, BA, Justin Choi, BA, Thomas Pritchard, MPH, Deepa Patel, MD, Anna L. Grossberg, MD, Shawn G. Kwatra, MD
#384 - Progressive and sustained improvements in the extent and severity of atopic dermatitis with tralokinumab in combination with topical corticosteroids as needed in moderate-to-severe atopic dermatitis
Andrew F. Alexis, Matthew Zirwas, Andreas Pinter, David N. Adam, Andrea Chiricozzi, Andrew E. Pink, Thomas Mark, Ann-Marie Tindberg, Jonathan I. Silverberg
#385 - Early and sustained improvements in patient-reported outcomes with tralokinumab in combination with topical corticosteroids as needed in moderate-to-severe atopic dermatitis
Boni E. Elewski, Sonja Ständer, Matthew Zirwas, Juan Francisco Silvestre, Sunil Kalia, Jan Gutermuth, Thomas Mark, Ann-Marie Tindberg, Jonathan I. Silverberg
#390 - Results from ADVISE: a randomized, double-blind, placebo-controlled phase 2 study of etrasimod, an oral, selective, sphingosine 1-phosphate receptor modulator, in adults with moderate-to-severe atopic dermatitis
Jonathan I. Silverberg, Robert Bissonnette, Leon Kircik, Dedee F. Murrell, Gurpreet Ahluwalia, Andrew Selfridge, Kris Liu, Emma Guttman-Yassky
#398 - Disease burden and impact on quality of life among adult Hispanics and non-Hispanics with Atopic Dermatitis: a population based cross-sectional study in the United States
#399 - International observational atopic dermatitis cohort to follow natural history and treatment course: TARGET-DERM AD study design and rationale
Katrina Abuabara, Jonathan I Silverberg, Eric L Simpson, Amy S Paller, Lawrence F Eichenfield, Robert Bissonnette, James Krueger, John E Harris, Laura Dalfonso, Janet S Hildebrand, Julie M Crawford, Diamant Thaci, Emma Guttman-Yassky